Tiny Gems Archives - Page 12 of 20

Monday Jan 23, 2023 - 11:42 am

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) to Present at Emerging Growth Conference

QSAM Biosciences (OTCQB: QSAM) is developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases and conditions. The company today announced that it has been invited to present at the Emerging Growth Conference at 10:15 a.m. ET on Wednesday, Jan. 25, 2023. Leading QSAM’s presentation will be the company’s CEO Douglas Baum and other executive officers, who may subsequently…

Monday Jan 23, 2023 - 10:15 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Unveils Streamlined, Automated Carrier Onboarding Process

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning, offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region, has announced a new, automated and effortless carrier onboarding process. The new process, states the company, makes it even easier qualified carriers to sign up and move loads with Fr8App. The…

Friday Jan 20, 2023 - 12:26 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Reaches Pivotal Milestone to Advance ADI (TM) Technology

Aditxt (NASDAQ: ADTX) recently announced the formation of a U.S.-based wholly owned subsidiary, Adimune Inc., and appointed Joachim-Friedrich Kapp, MD, Ph.D, a 30-year veteran of the pharmaceutical industry, as its chairman and CEO. “Dr. Kapp will be tasked with leading and developing the ADI(TM) immune modulation technology and ADI(TM)-100, Aditxt’s unique and potent antigen-specific immunotherapeutic technology drug candidate, toward clinical trials… Short for Apoptotic DNA…

Friday Jan 20, 2023 - 10:29 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Completed $100M Koito Manufacturing Investment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has closed its previously announced $100 million investment with Koito Manufacturing Co. Ltd.; Koito is a long-term automotive Tier 1 partner and current CPTN shareholder. The transaction closed on Jan. 19, 2023, and was in the form of convertible preferred stock. Cepton’s stockholders approved the move at a special meeting held on Jan.…

Thursday Jan 19, 2023 - 9:52 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Contract Renewals for Multiple Key Clients

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and emergency systems, announced that seven key clients have renewed their contracts for another year. The renewal agreements include a hospital, hotel, bank, commercial property developer, mass media company, and two residential communities, representing clients from a variety of industries. Knightscope’s innovative solutions have enabled these clients to reduce crime rates and improve security operations…

Wednesday Jan 18, 2023 - 12:25 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Collaborates to Further Unlock Potential of Its Lidar Technology Across Robotics Applications

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently announced that it would be further broadening its technological reach by collaborating with Exwayz to develop novel lidar-based perception solutions for mobile robotics applications. “Exwayz is a developer of plug-and-play perception software designed to enable lidar-based 3D mapping, localization, and re-localization as well as object detection and classification… The venture’s lidar-based…

Wednesday Jan 18, 2023 - 10:06 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Promising Results from Kernel Flow(R) Feasibility Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced key highlights from the completed feasibility study conducted by its partner HI, LLC dba Kernel (“Kernel”). The study was designed to evaluate Kernel’s Flow(R) wearable technology to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics. “The results from the feasibility study are very promising and provide further insights…

Tuesday Jan 17, 2023 - 9:56 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Provides Strategic Update in Annual Shareholder Letter

Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka has released an annual letter to shareholders. The detailed letter talks about company highlights throughout the year, including the fact that, despite challenges such as global supply chain disruptions and threatening inflation, “Lexaria continues to navigate well and is focused on those things it can control such as applied R&D designed to entice others to work with us…

Thursday Jan 12, 2023 - 2:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Closer Toward Broad Applications of Patented DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX) in 2022 achieved crucial milestones centered around its patented DehydraTECH(TM) drug delivery technology. “For Lexaria, the end goal does not only lie in uncovering DehydraTECH’s ability to improve the bioavailability of various APIs. Instead, the company is keen on establishing whether DehydraTECH can be applied broadly within the pharmaceutical industry. And calendar 2022 has brought Lexaria closer to realizing this…

Thursday Jan 12, 2023 - 12:39 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin to Be Evaluated in Investigator-Initiated Phase 1b/2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced an investigator-initiated phase 1b /2 trial evaluating the company’s novel anthracycline, Berubicin. The study, titled “Evaluation of the safety and efficacy of Berubicin in the treatment of central nervous system lymphomas,” will be conducted at the Pomeranian…

Thursday Jan 12, 2023 - 12:32 pm

InvestorNewsBreaks – Vision Energy Corp. (VENG) Issues Update on Recent Market Activity

Vision Energy (OTC: VENG) (the “Company”) today issued statements regarding recent removal from the OTCQB Market. On Dec. 6, 2022, Vision Energy was informed by the OTC Markets Group Inc. of certain promotional material that encouraged investors to purchase or trade the Company’s common stock. On Jan. 10, 2022, the Company was informed that, due to the ongoing promotional campaign, it would be moved from…

Thursday Jan 12, 2023 - 11:15 am

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Moves to Acquire MeridianBet Group

Golden Matrix Group (NASDAQ: GMGI) is a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content. The company today announced its entry into a definitive acquisition agreement pursuant to which it has agreed to acquire MeridianBet Group and its related companies in a cash and stock transaction valued at approximately $300 million. MeridianBet is Southeast Europe’s leading business-to-consumer (“B2C”)…

Thursday Jan 12, 2023 - 9:49 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Selects Generalized Anxiety Disorder as Target Indication for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(R). The company today announced that it has selected Generalized Anxiety Disorder (“GAD”) with or without major depressive disorder (“MDD”) as the target indication for CYB004 — its proprietary deuterated N, N-dimethyltryptamine (“DMT”) molecule. “Based on preclinical data, CYB004 has shown promise in treating anxiety disorders. About half of people…

Thursday Jan 12, 2023 - 9:26 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Announces Approval of Preferred Stock Issue by Shareholders

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, reported that its stockholders approved the company’s proposal to issue 100,000 shares of Series A Convertible Preferred Stock to Koito Manufacturing Co. Ltd. The issuance, which would be for $100 million, is based on the terms of an investment agreement between the two companies that was signed on Oct. 27, 2022. According to…

Wednesday Jan 11, 2023 - 12:04 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Dedicated to New Era of Precision Medicine

Aditxt (NASDAQ: ADTX), a biotech innovation company, is developing and commercializing technologies with a focus on monitoring and modulating, mapping and reprogramming the immune system, designing technologies to provide a personalized immune profile. “In late October 2022, Aditxt announced the creation of its Adimune(TM) program. At the same time, Aditxt announced that Adimune initiated the GMP manufacturing of drug candidate ADI(TM)-100 for purposes of initiating…

Tuesday Jan 10, 2023 - 12:13 pm

InvestorNewsBreaks – Vision Energy Corp. (VENG) Incorporates Dutch Subsidiaries

Vision Energy (OTCQB: VENG), a forward-looking energy company developing carbon reduced solutions for the commercial, industrial and transportation sector, has incorporated new Dutch subsidiaries. These incorporations are designed to accommodate strategic initiatives for prospective partners, operators and launching customers for VENG’s integrated Green Energy Hub development in North Sea Port of Vlissingen, the Netherlands. According to the announcement, Vision Energy incorporated Vision Hydrogen BV as a…

Tuesday Jan 10, 2023 - 11:02 am

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Releases Shareholder Letter Outlining 2022 Updates, 2023 Milestone Goals

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has provided key updates and milestone goals in a shareholder letter; the letter is from QSAM Biosciences executive chair and cofounder C. Richard Piazza and CEO and cofounder Douglas Baum. The letter noted that QSAM is developing its lead therapeutic radiopharmaceutical drug candidate,…

Tuesday Jan 10, 2023 - 10:20 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlined key accomplishments from 2022 and provided a business update and catalysts for 2023. “Over the course of 2022, we strengthened our position as a leader in rare cannabinoid R&D, creating a unique offering as the only company that has the breadth and depth in…

Monday Jan 09, 2023 - 2:05 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Kicks Off New Year with Multiple New Contracts, Announces Planned Path to Profitability

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that it has secured four new contracts in a successful start of 2023. Under the contracts, Knightscope will deploy three K5 Autonomous Security Robots (“ASRs”) and five K1 Blue Light Towers. The deployment locations include an existing Knightscope channel partner’s regional corporate office in Jacksonville, Florida, an Illinois-based…

Monday Jan 09, 2023 - 1:11 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space

Flora Growth Corp. (NASDAQ: FLGC), a cannabis cultivator and global distributor, is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena. “Much of Flora Growth’s strength lies in its licensed cultivation, extraction and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping…

Monday Jan 09, 2023 - 12:20 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Poised to Potentially Change History

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is enrolling patients in the United States and Europe for its potentially pivotal global clinical trial in humans for its lead drug candidate designed to treat glioblastoma multiforme (“GBM”), a common and one of the most aggressive primary brain cancers. “The drug, Berubicin, is an anthracycline chemotherapy agent that apparently has the unique ability to cross the blood-brain…

Friday Jan 06, 2023 - 1:00 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Releases Projections for Double-Digit Revenue Growth in 2023

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for business-to-business, cross-border shipping in the USMCA region, has announced its 2023 guidance for revenue. According to the announcement, the company anticipates revenue this year to reach somewhere between $36 to $42 million; the company reported 2022 revenue of approximately $26 to $27…

Friday Jan 06, 2023 - 10:59 am

InvestorNewsBreaks – Cepton Inc.’s (NASDAQ: CPTN) Vista-X120 Plus Featured in FreightWaves Article

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, was featured in a recent article published by FreightWaves. The piece, written by Jack Daleo and titled “Cepton unveils slimmed-down lidar solution,” discusses the Vista-X120 Plus, which offers easy integration at a height of 30 mm. “As the autonomous vehicle industry begins to gather steam, manufacturers of lidar — short for light detection and…

Thursday Jan 05, 2023 - 1:15 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Secures Stream of Steady Business on Fr8App Platform

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a company specializing in creating and providing supply chain optimization and automation solutions, and Freight App Inc. (“Fr8App”), its wholly owned subsidiary, have always sought to create offerings that contribute to their clients’ success by improving efficiency and profitability. “Designed to help solve shippers’ needs to secure freight capacity over time rather than on a trip-by-trip basis and guarantee carriers…

Thursday Jan 05, 2023 - 12:20 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at Virtual Investor 2023 ‘Companies to Watch’

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will present at the Virtual Investor 2023 “Companies to Watch” event. Climaco’s presentation is scheduled to take place beginning at 10 a.m. ET on Wednesday, Jan. 18,…

Wednesday Jan 04, 2023 - 1:37 pm

InvestorNewsBreaks – Vision Energy Corp.’s (VENG) Pioneering Terminal Set to Accelerate Energy Transition

Vision Energy (OTCQB: VENG) recently entered into a corporation agreement with Linde Engineering to accelerate efforts for the company’s pioneering Green Energy Terminal in the North Sea Port of Vlissingen, the Netherlands. “Linde Engineering, a leading global industrial gases and engineering company with 2021 sales of $31 billion, will deliver preliminary Front-End Engineering and Design (‘FEED’) services to the project including design and engineering of…

Tuesday Jan 03, 2023 - 2:33 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Strategic Board Appointment of Faith L. Charles, JD

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Faith L. Charles as chair of its board of directors. Since 2010, Charles has served as a corporate transactions and securities partner at the law firm of Thompson Hine, LLP. She currently leads the…

Tuesday Jan 03, 2023 - 1:06 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms Subsidiary with Focus on Immune Modulation Therapies

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system. The company today announced the formation of a U.S.-based subsidiary Adimune Inc. (“Adimune(TM)”) and its plans towards submission of a clinical trial application (“CTA”) for its immunotherapeutic technology drug candidate, ADI(TM)-100. The CTA application will request approval for Adimune to conduct the first-in-human…

Tuesday Jan 03, 2023 - 10:27 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Deploy Seven ASRs for Multiple New Contracts

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced four new contracts totaling seven Autonomous Security Robots (“ASRs”) as part of the company’s year-end push to support its commitment to continue adding to its top-line revenue. The contracts and deployment locations include a Houston-based top commercial real estate brokerage firm and a manufacturer of premium quality…

Tuesday Jan 03, 2023 - 10:00 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) to Support Global Industrial Electric Manufacturer with Logistics Management Solution

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed Fr8App platform is powered by AI and machine-learning and offers a real-time portal for B2B cross-border shipping and domestic shipping within the United States-Mexico-Canada (“USMC”) region. The company today announced that it now supports cross-border logistics requirements for a global electric-electronic equipment company with eighteen different factories and distribution centers across the U.S. and…

Thursday Dec 29, 2022 - 12:00 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures 28th Patent in International Portfolio

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its continued accumulation of international patent recognition with the receipt of its first granted patent in Canada, which is its 28th granted patent worldwide. According to the update, Canadian Patent #3,093,414 is the first granted patent from Lexaria’s sixth patent family and is entitled “Transdermal and/or Dermal Delivery of Lipophilic Active…

Tuesday Dec 27, 2022 - 11:18 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast, Secures New Contracts Spanning Multiple States

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release highlights Knightscope’s recent securement of its largest single contract to date alongside two new contracts from cities in New York and…

Tuesday Dec 27, 2022 - 11:08 am

InvestorNewsBreaks – Vision Energy Corp. (VENG) Increases Core Team to Realize Project Development Objectives

Vision Energy (OTCQB: VENG) today provided an update on the expansion of its project management and development team. According to the announcement, Vision Energy, through its wholly owned Dutch subsidiary Evolution Terminals BV (“ETBV”), continues work to realize its project development objectives and has increased its core team of experienced commercial and engineering professionals. Since its December 2020 incorporation, ETBV has been executing its mission…

Tuesday Dec 27, 2022 - 10:28 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes on Acquisition of Multinational Medical Cannabis Operator

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has completed a “plan of arrangement,” or acquisition, of Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry with principal operations in Germany. Shareholders of Global Health Inc. approved the plan, which was effective as of Dec. 23, 2022. FLGC anticipates that…

Thursday Dec 22, 2022 - 10:42 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces I-GO European Arrival

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its I-GO(TM) Commercial Urban Delivery EV has arrived in Europe; specifically, sample vehicles are on their way to Ireland-based Newgate Motor Group, with an expected delivery for early next month. Initially, delivery was scheduled for December, but COVID-related shutdown issues caused the delay. According to the announcement, Mullen’s I-GO is an urban…

Wednesday Dec 21, 2022 - 3:23 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ASR and Emergency Communication Services for Five New Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced continued market expansion through securing five new contracts for its Autonomous Security Robot (“ASR”) and Blue Light Emergency Communication services across multiple U.S. states. The contracts and deployment locations include a property management group in Chicago, a police department in North Carolina, another tribal casino client in Oklahoma, an airport in New Jersey,…

Wednesday Dec 21, 2022 - 2:33 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD (TM) Achieves Superior CBD Blood Absorption Levels in Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has demonstrated superior cannabidiol (“CBD”) blood absorption levels from its patented DehydraTECH-CBD(TM) relative to those of published, pharmaceutical-grade CBD industry comparators. The results were obtained from the company’s recently completed, multi-week human clinical hypertension study – HYPER-H21-4. “DehydraTECH-CBD has repeatedly shown that it can be administered at much lower…

Wednesday Dec 21, 2022 - 1:51 pm

InvestorNewsBreaks – Vision Energy Corp. (VENG) Issues Development Update on Green Energy Hub

Vision Energy (OTCQB: VENG) today provided a project development update on the company’s Green Energy Hub in the North Sea Port of Vlissingen, the Netherlands. According to the update, Vision Energy, through its wholly owned subsidiary Evolution Terminals BV, is concluding remaining requisite studies to support filing permit applications under the Dutch “WABO” process, with targeted first submission by Dec. 31, 2022. The submission includes…

Tuesday Dec 20, 2022 - 3:06 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured…

Tuesday Dec 20, 2022 - 11:52 am

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 21st Annual J.P. Morgan Tech/Auto Forum

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 21st Annual J.P. Morgan Tech/Auto Forum. The forum is slated to take place at the Bellagio Hotel during CES 2023 in Las Vegas, Nevada, on Jan. 5, 2023. Cepton will participate…

InvestorNewsBreaks

NewsBreak Category: Tiny Gems

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions